Atrial Natriuretic Peptide (ANP) (1-28), human, porcine
Atrial natriuretic peptide (ANP), a stimulator of particulate guanylate cyclase, has been found to protect against reoxygenation-induced hypercontracture in isolated cardiomyocytes by increasing cyclic guanosine monophosphate synthesis; ANP also contributes to stimulation of lipolysis during repeated bouts of exercise and in the control of lipolysis during exercise.
RP11927 | |
|
|
¥17,219.00 | |
|
|
|
|
Ask us a question |